Legislation in House of Representatives to Expand Pro Vaccine Messaging and Vaccine Surveillance
A bill introduced in the U.S. House of Representatives on Apr. 21, 2026 would use billions of dollars in Medicaid funding to pressure states into adopting federally approved vaccine messaging and expand the U.S. government’s surveillance of children’s vaccination records. Introduced by Representative Kim Schrier, MD of Washington, H.R. 8425, the Strengthening the Vaccines for […]
Rising Rates of Colorectal Cancer in Young Adults Linked to Bayer’s RoundUp Weedkiller
A peer-reviewed study published Apr. 21, 2026, in Nature Medicine by researchers in Spain has found that rising early-onset colorectal cancer in younger adults is linked to pesticide exposure via herbicides containing ingredients banned in other countries but still approved for use in the United States.1 The study evaluated “epigenetic fingerprints” left in tumor DNA […]
Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
“Vocal Supporter” of Vaccines Nominated to Be CDC Director
On Apr. 17, 2026, the Trump administration nominated retired Coast Guard rear admiral and former deputy surgeon general Erica Schwartz, MD, JD, MPH to be the next director of the U.S. Centers for Disease Control and Prevention (CDC). If confirmed by the U.S. Senate, Dr. Schwartz would succeed Jay Bhattacharya, MD, PhD who has been […]
Public-Private Partnership Builds Africa’s First Multi-Vaccine Production Plant
European investors have announced their partnership with South African biopharmaceutical company The Biovac Institute in building Africa’s first end-to-end multi-vaccine manufacturing facility in South Africa. Biovac projects to annually produce tens of millions of doses of vaccines for cholera, polio, and pneumonia. The plant will be the continent’s first end-to-end vaccine manufacturing plant, and the […]
Parkinson’s Disease Costs Projected to Reach $112 Billion by 2045
According to an economic burden analysis commissioned by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), the total economic impact of Parkinson’s disease in the United States is projected to reach $112 billion by 2045, representing a substantial increase over current estimates. The analysis evaluated direct medical, indirect, and non-medical costs and reflects a […]